Gene: TDRD9
Official Full Name: tudor domain containing 9provided by HGNC
Gene Summary: Predicted to enable ATP hydrolysis activity; RNA binding activity; and helicase activity. Involved in spermatogenesis. Located in cytoplasm and nucleus. Implicated in spermatogenic failure 30. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28930 | TDRD9 Knockout cell line (HeLa) | Human | TDRD9 | 1:3~1:6 | Negative | Online Inquiry |
TDRD9 Gene Knockout Cell Lines are genetically engineered cell lines in which the TDRD9 gene has been disrupted, providing a powerful tool for studying the gene's biological functions and contributions to cellular processes. TDRD9 (Tudor Domain Containing 9) is known to be involved in the regulation of gene expression and RNA metabolism, making the knockout model invaluable for dissecting the molecular pathways it influences. The disruption of TDRD9 allows researchers to observe the resulting phenotypic changes and gain insights into its role in processes such as germ cell development and epigenetic regulation.
These cell lines function primarily by enabling the observation of cellular behaviors and signaling pathways that are altered due to the absence of TDRD9, utilizing methodologies such as CRISPR/Cas9 gene-editing technology to ensure precise and reliable gene knockout. This mechanism permits researchers to study the downstream effects and compensatory mechanisms triggered by TDRD9 loss, providing a clearer understanding of its integral role in normal physiology and disease states.
The scientific importance of TDRD9 Gene Knockout Cell Lines extends to various research applications, including developmental biology, reproductive health research, and cancer studies, where aberrations in gene regulation often contribute to pathogenesis. By utilizing these cell lines, researchers can develop targeted therapies and biomarkers, paving the way for clinical advancements.
Compared to alternative methods such as RNA interference (RNAi), which offers temporary depletion, TDRD9 Gene Knockout Cell Lines provide a stable and permanent gene loss model that enhances reproducibility and reliability in experimental outcomes. Moreover, the ability to use these knockout lines in a range of cellular assays increases their applicability across diverse research contexts.
For researchers, clinicians, and geneticists looking to understand the multifaceted roles of TDRD9 in health and disease, these knockouts represent a leap forward in experimental rigor. Our company prides itself on its commitment to providing high-quality, validated biological products that empower the scientific community. With a focus on innovation and precision, our offerings enable pivotal discoveries that contribute to advancements in biomedical research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.